课题基金 / 基金详情

An animal model of Lam bert-Eaton myasthenic syndrome using adeovirus expressing a1A subunit of P/Q-type voltage-gated calcium channel

An animal model of Lam bert-Eaton myasthenic syndrome using adeovirus expressing a1A subunit of P/Q-type voltage-gated calcium channel
使用表达 P/Q 型电压门控钙通道 a1A 亚基的腺病毒建立 Lam bert-Eaton 肌无力综合征动物模型
批准号:
15590896
负责人:
MOTOMURA Masakatsu
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

MOTOMURA Masakatsu的其他基金

相似基金

相关文献

中文摘要
翻译
Lambert-Eaton肌无力综合征(LEMS)是一种神经肌肉传递的自身免疫性疾病,其中IgG自身抗体导致突触前电压门控钙通道(VGCC)丢失。作为一种副肿瘤性疾病,60%的LEMS患者患有表达功能性VGCC的小细胞肺癌。在<125>85-95%的LEMS患者中可以检测到使用β I-ω-芋螺毒素MVIIC检测抗P/Q型VGCC抗体的诊断性放射免疫测定。这一结果表明,P/Q型钙通道的抗体是主要的致病因素。然而,LEMS中的自身抗体是异质性的,因为已经鉴定了针对不同VGCC亚型和突触结合蛋白的抗体。为了阐明LEMS的发病机制,我们利用表达P/Q型电压门控性钙通道α 1A亚单位的腺病毒建立了LEMS动物模型。因此,我们不能建立LEMS的动物模型.原因是我们不能制造表达P/Q型电压门控钙通道a1 A亚单位的腺病毒,因为其分子尺寸非常大。现在我们正在考虑另一种策略。
英文摘要
The Lambert-Eaton myasthenic syndrome(LEMS) is an autoimmune disorder of neuromuscular transmission in which IgG autoantibodies lead to presynaptic voltage-gated calcium channel(VGCC) loss. As a paraneoplastic disorder, 60% of patients with LEMS have small cell lung carcinoma that express functional VGCCs. A diagnostic radioimmunoassay to detect anti-P/Q-type VGCC antibodies using ^<125>I-ω-conotoxin MVIIC can be detected in 85-95% of LEMS patients. This result suggests that antibodies to P/Q-type calcium channels are the principal pathogenic factor. However, autoantibodies in LEMS are heterogeneous because antibodies against different VGCC subtypes and synaptotagmin have been identified. To clarify the pathogenesis of LEMS, we made a plan of LEMS animal model using adeovirus expressing a1A subunit of P/Q-type voltage-gated calcium channel. In conclusion, we can not make an animal model of LEMS. The reason is that we was not able to make an adenovirus expressing a1A subunit of P/Q-type voltage-gated calcium channel because its molecular size is very huge. Now we are considering another strategy.
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
Paraneoplastic cerebellar degeneration and antibodies to P/Q-type calcium channels.
副肿瘤性小脑变性和 P/Q 型钙通道抗体。
DOI: --
发表时间: 2003
期刊: Ann Neurol 54(2)
影响因子: --
作者: [M Motomura, et al.]
通讯作者: et al.
DOI: 10.1016/j.jneuroim.2004.01.022
发表时间: 2004-05
期刊: Journal of Neuroimmunology
影响因子: 3.3
作者: [M. Matsumoto;H. Matsuo;T. Oka;T. Fukudome;K. Hayashi;H. Shiraishi;M. Motomura;N. Shibuya;H. Ayabe]
通讯作者: M. Matsumoto;H. Matsuo;T. Oka;T. Fukudome;K. Hayashi;H. Shiraishi;M. Motomura;N. Shibuya;H. Ayabe
Anti-ryanodine antimodies and FK506 in myasthenia gravis.
重症肌无力中的抗兰尼定抗体和 FK506。
DOI: --
发表时间: 2004
期刊: Neurology 62(10)
影响因子: --
作者: [Takamori M, Moromura M, et al.]
通讯作者: et al.
Nagashima T, et al.: "Anti-Hu paraneoplastic syndrome presenting with brainstem-cerebellar symptoms and Lambent-Eaton myasthenic syndrome"Neuropathology. 23(3). 230-238 (2003)
Nagashima T 等人:“Anti-Hu 副肿瘤综合征表现为脑干小脑症状和 Lambent-Eaton 肌无力综合征”神经病理学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 18 条
    Clinical pictures and neuromuscular junction pathomechanism in novel LDL- recepotr related protein 4 antibody-positive myasthenia gravis
    Pathomechanism of myasthenia gravis using experimental autoimmune MuSK antibody-positive animal model
    • 批准号:
      19590998
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      MOTOMURA Masakatsu
    • 依托单位:
    Experimental autoimmune MuSK antibody-induced myasthenia gravis
    • 批准号:
      17590883
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2005
    • 负责人:
      MOTOMURA Masakatsu
    • 依托单位:
    Analysis of the P/Q-type calcium channel in autopsied patients with paraneoplastic cerebellar degeneration (PCD) and Lambert-Eaton myasthenic syndrome (LEMS)
    • 批准号:
      13670654
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2001
    • 负责人:
      MOTOMURA Masakatsu
    • 依托单位:
    国内基金
    海外基金
    miR-30c-5p通过MTDH/HIF-1α/PKM2环形反馈抑制乳腺癌进展的作用及机制研究
    精草铵膦生物合成中C-P键的酶促构建
    • 批准号:
      JCZRLH202601890
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    AOC4P调控TRAF6-EZH2轴驱动巨噬细胞极化影响多囊卵巢综合征炎症反应的分子机制
    • 批准号:
      JCZRLH202602076
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    间充质干细胞外泌体携带miR-455-3p干预急性移植物抗宿主病的机制研究